Women identified as at risk will be invited for check-ups over the next 12 months
2020 saw an estimated 8.8 million cancer cases in women globally
The boards of directors of both companies have unanimously approved the transaction
CardieX and Power are hoping to shift the paradigm on clinical trial diversity
The company aims to reverse the rise of late-stage cervical cancer and get women up to date on their screenings
Over 70 per cent of women have delayed getting a Pap test, the US medtech company BD has found
The interval between smear tests can safely be extended, experts say
